Table of Contents Executive Summary 1 Industry Overview of Neurodegenerative Drugs 1.1 Definition of Neurodegenerative Drugs 1.2 Neurodegenerative Drugs Segment by Type 1.2.1 Global Neurodegenerative Drugs Production Growth Rate Comparison by Types (2014-2025) 1.2.2 NMDA 1.2.3 SSRIs 1.2.4 Dopamine Inhibitors 1.3 Neurodegenerative Drugs Segment by Applications 1.3.1 Global Neurodegenerative Drugs Consumption Comparison by Applications (2014-2025) 1.3.2 Hospital 1.3.3 Research 1.4 Global Neurodegenerative Drugs Overall Market 1.4.1 Global Neurodegenerative Drugs Revenue (2014-2025) 1.4.2 Global Neurodegenerative Drugs Production (2014-2025) 1.4.3 North America Neurodegenerative Drugs Status and Prospect (2014-2025) 1.4.4 Europe Neurodegenerative Drugs Status and Prospect (2014-2025) 1.4.5 China Neurodegenerative Drugs Status and Prospect (2014-2025) 1.4.6 Japan Neurodegenerative Drugs Status and Prospect (2014-2025) 1.4.7 Southeast Asia Neurodegenerative Drugs Status and Prospect (2014-2025) 1.4.8 India Neurodegenerative Drugs Status and Prospect (2014-2025) 2 Manufacturing Cost Structure Analysis 2.1 Raw Material and Suppliers 2.2 Manufacturing Cost Structure Analysis of Neurodegenerative Drugs 2.3 Manufacturing Process Analysis of Neurodegenerative Drugs 2.4 Industry Chain Structure of Neurodegenerative Drugs 3 Development and Manufacturing Plants Analysis of Neurodegenerative Drugs 3.1 Capacity and Commercial Production Date 3.2 Global Neurodegenerative Drugs Manufacturing Plants Distribution 3.3 Major Manufacturers Technology Source and Market Position of Neurodegenerative Drugs 3.4 Recent Development and Expansion Plans 4 Key Figures of Major Manufacturers 4.1 Neurodegenerative Drugs Production and Capacity Analysis 4.2 Neurodegenerative Drugs Revenue Analysis 4.3 Neurodegenerative Drugs Price Analysis 4.4 Market Concentration Degree 5 Neurodegenerative Drugs Regional Market Analysis 5.1 Neurodegenerative Drugs Production by Regions 5.1.1 Global Neurodegenerative Drugs Production by Regions 5.1.2 Global Neurodegenerative Drugs Revenue by Regions 5.2 Neurodegenerative Drugs Consumption by Regions 5.3 North America Neurodegenerative Drugs Market Analysis 5.3.1 North America Neurodegenerative Drugs Production 5.3.2 North America Neurodegenerative Drugs Revenue 5.3.3 Key Manufacturers in North America 5.3.4 North America Neurodegenerative Drugs Import and Export 5.4 Europe Neurodegenerative Drugs Market Analysis 5.4.1 Europe Neurodegenerative Drugs Production 5.4.2 Europe Neurodegenerative Drugs Revenue 5.4.3 Key Manufacturers in Europe 5.4.4 Europe Neurodegenerative Drugs Import and Export 5.5 China Neurodegenerative Drugs Market Analysis 5.5.1 China Neurodegenerative Drugs Production 5.5.2 China Neurodegenerative Drugs Revenue 5.5.3 Key Manufacturers in China 5.5.4 China Neurodegenerative Drugs Import and Export 5.6 Japan Neurodegenerative Drugs Market Analysis 5.6.1 Japan Neurodegenerative Drugs Production 5.6.2 Japan Neurodegenerative Drugs Revenue 5.6.3 Key Manufacturers in Japan 5.6.4 Japan Neurodegenerative Drugs Import and Export 5.7 Southeast Asia Neurodegenerative Drugs Market Analysis 5.7.1 Southeast Asia Neurodegenerative Drugs Production 5.7.2 Southeast Asia Neurodegenerative Drugs Revenue 5.7.3 Key Manufacturers in Southeast Asia 5.7.4 Southeast Asia Neurodegenerative Drugs Import and Export 5.8 India Neurodegenerative Drugs Market Analysis 5.8.1 India Neurodegenerative Drugs Production 5.8.2 India Neurodegenerative Drugs Revenue 5.8.3 Key Manufacturers in India 5.8.4 India Neurodegenerative Drugs Import and Export 6 Neurodegenerative Drugs Segment Market Analysis (by Type) 6.1 Global Neurodegenerative Drugs Production by Type 6.2 Global Neurodegenerative Drugs Revenue by Type 6.3 Neurodegenerative Drugs Price by Type 7 Neurodegenerative Drugs Segment Market Analysis (by Application) 7.1 Global Neurodegenerative Drugs Consumption by Application 7.2 Global Neurodegenerative Drugs Consumption Market Share by Application (2014-2019) 8 Neurodegenerative Drugs Major Manufacturers Analysis 8.1 Novartis 8.1.1 Novartis Neurodegenerative Drugs Production Sites and Area Served 8.1.2 Novartis Product Introduction, Application and Specification 8.1.3 Novartis Neurodegenerative Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019) 8.1.4 Main Business and Markets Served 8.2 Pfizer 8.2.1 Pfizer Neurodegenerative Drugs Production Sites and Area Served 8.2.2 Pfizer Product Introduction, Application and Specification 8.2.3 Pfizer Neurodegenerative Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019) 8.2.4 Main Business and Markets Served 8.3 Merck Serono 8.3.1 Merck Serono Neurodegenerative Drugs Production Sites and Area Served 8.3.2 Merck Serono Product Introduction, Application and Specification 8.3.3 Merck Serono Neurodegenerative Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019) 8.3.4 Main Business and Markets Served 8.4 Biogen Idec 8.4.1 Biogen Idec Neurodegenerative Drugs Production Sites and Area Served 8.4.2 Biogen Idec Product Introduction, Application and Specification 8.4.3 Biogen Idec Neurodegenerative Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019) 8.4.4 Main Business and Markets Served 8.5 TEVA Pharmaceuticals 8.5.1 TEVA Pharmaceuticals Neurodegenerative Drugs Production Sites and Area Served 8.5.2 TEVA Pharmaceuticals Product Introduction, Application and Specification 8.5.3 TEVA Pharmaceuticals Neurodegenerative Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019) 8.5.4 Main Business and Markets Served 8.6 UCB 8.6.1 UCB Neurodegenerative Drugs Production Sites and Area Served 8.6.2 UCB Product Introduction, Application and Specification 8.6.3 UCB Neurodegenerative Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019) 8.6.4 Main Business and Markets Served 8.7 Boehringer Ingelheim 8.7.1 Boehringer Ingelheim Neurodegenerative Drugs Production Sites and Area Served 8.7.2 Boehringer Ingelheim Product Introduction, Application and Specification 8.7.3 Boehringer Ingelheim Neurodegenerative Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019) 8.7.4 Main Business and Markets Served 8.8 Sanofi 8.8.1 Sanofi Neurodegenerative Drugs Production Sites and Area Served 8.8.2 Sanofi Product Introduction, Application and Specification 8.8.3 Sanofi Neurodegenerative Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019) 8.8.4 Main Business and Markets Served 8.9 GlaxoSmithKline 8.9.1 GlaxoSmithKline Neurodegenerative Drugs Production Sites and Area Served 8.9.2 GlaxoSmithKline Product Introduction, Application and Specification 8.9.3 GlaxoSmithKline Neurodegenerative Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019) 8.9.4 Main Business and Markets Served 9 Development Trend of Analysis of Neurodegenerative Drugs Market 9.1 Global Neurodegenerative Drugs Market Trend Analysis 9.1.1 Global Neurodegenerative Drugs Market Size (Volume and Value) Forecast 2019-2025 9.2 Neurodegenerative Drugs Regional Market Trend 9.2.1 North America Neurodegenerative Drugs Forecast 2019-2025 9.2.2 Europe Neurodegenerative Drugs Forecast 2019-2025 9.2.3 China Neurodegenerative Drugs Forecast 2019-2025 9.2.4 Japan Neurodegenerative Drugs Forecast 2019-2025 9.2.5 Southeast Asia Neurodegenerative Drugs Forecast 2019-2025 9.2.6 India Neurodegenerative Drugs Forecast 2019-2025 9.3 Neurodegenerative Drugs Market Trend (Product Type) 9.4 Neurodegenerative Drugs Market Trend (Application) 10.1 Marketing Channel 10.1.1 Direct Marketing 10.1.2 Indirect Marketing 10.3 Neurodegenerative Drugs Customers 11 Market Dynamics 11.1 Market Trends 11.2 Opportunities 11.3 Market Drivers 11.4 Challenges 11.5 Influence Factors 12 Conclusion 13 Appendix 13.1 Methodology/Research Approach 13.1.1 Research Programs/Design 13.1.2 Market Size Estimation 13.1.3 Market Breakdown and Data Triangulation 13.2 Data Source 13.2.1 Secondary Sources 13.2.2 Primary Sources 13.3 Author List 13.4 Disclaimer

List of Tables and Figures Figure Picture of Neurodegenerative Drugs Table Global Neurodegenerative Drugs Production (MT) Growth Rate Comparison by Types (2014-2025) Figure Global Neurodegenerative Drugs Production Market Share by Types in 2018 Figure NMDA Product Picture Figure SSRIs Product Picture Figure Dopamine Inhibitors Product Picture Table Global Neurodegenerative Drugs Consumption (MT) Comparison by Applications (2014-2025) Figure Global Neurodegenerative Drugs Consumption Market Share by Applications in 2018 Figure Hospital Figure Research Figure Global Neurodegenerative Drugs Revenue (Million USD) (2014-2025) Figure Global Neurodegenerative Drugs Production (MT) (2014-2025) Figure North America Neurodegenerative Drugs Market Size (Million USD) (2014-2025) Figure Europe Neurodegenerative Drugs Market Size (Million USD) (2014-2025) Figure China Neurodegenerative Drugs Market Size (Million USD) (2014-2025) Figure Japan Neurodegenerative Drugs Market Size (Million USD) (2014-2025) Figure Southeast Asia Neurodegenerative Drugs Market Size (Million USD) (2014-2025) Figure India Neurodegenerative Drugs Market Size (Million USD) (2014-2025) Table Neurodegenerative Drugs Raw Material and Suppliers Table Manufacturing Cost Structure Analysis of Neurodegenerative Drugs in 2018 Figure Manufacturing Process Analysis of Neurodegenerative Drugs Figure Industry Chain Structure of Neurodegenerative Drugs Table Capacity and Commercial Production Date of Key Manufacturers Table Global Neurodegenerative Drugs Manufacturing Plants Distribution Table Neurodegenerative Drugs Major Manufacturers Technology Source and Market Position Table Recent Development and Expansion Plans in Future Table Neurodegenerative Drugs Capacity (MT) of Major Manufacturers (2014-2019) Table Neurodegenerative Drugs Production (MT) of Major Manufacturers (2014-2019) Table Neurodegenerative Drugs Production Market Share of Major Manufacturers (2014-2019) Figure Neurodegenerative Drugs Production Share by Manufacturers in 2018 Table Neurodegenerative Drugs Revenue (Million US$) of Major Manufacturers (2014-2019) Table Neurodegenerative Drugs Revenue Market Share of Major Manufacturers (2014-2019) Figure Neurodegenerative Drugs Revenue Share by Manufacturers in 2018 Table Neurodegenerative Drugs Average Price (USD/Kg) of Major Manufacturers (2014-2019) Table Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table Global Neurodegenerative Drugs Production by Regions 2014-2019 (MT) Table Global Neurodegenerative Drugs Production Market Share by Regions 2014-2019 Figure Global Neurodegenerative Drugs Production Market Share by Regions in 2018 Table Global Neurodegenerative Drugs Revenue by Regions 2014-2019 (Million USD) Table Global Neurodegenerative Drugs Revenue Market Share by Regions 2014-2019 Figure Global Neurodegenerative Drugs Revenue Market Share by Regions in 2018 Table Global Neurodegenerative Drugs Consumption by Regions 2014-2019 (MT) Table Global Neurodegenerative Drugs Consumption Market Share by Regions 2014-2019 Figure North America Neurodegenerative Drugs Production Growth Rate 2014-2019 (MT) Figure North America Neurodegenerative Drugs Revenue Growth Rate 2014-2019 (Million USD) Table North America Neurodegenerative Drugs Production, Consumption Import and Export (MT) Figure Europe Neurodegenerative Drugs Production Growth Rate 2014-2019 (MT) Figure Europe Neurodegenerative Drugs Revenue Growth Rate 2014-2019 (Million USD) Table Europe Neurodegenerative Drugs Production, Consumption Import and Export (MT) Figure China Neurodegenerative Drugs Production Growth Rate 2014-2019 (MT) Figure China Neurodegenerative Drugs Revenue Growth Rate 2014-2019 (Million USD) Table China Neurodegenerative Drugs Production, Consumption Import and Export (MT) Figure Japan Neurodegenerative Drugs Production Growth Rate 2014-2019 (MT) Figure Japan Neurodegenerative Drugs Revenue Growth Rate 2014-2019 (Million USD) Table Japan Neurodegenerative Drugs Production, Consumption Import and Export (MT) Figure Southeast Asia Neurodegenerative Drugs Production Growth Rate 2014-2019 (MT) Figure Southeast Asia Neurodegenerative Drugs Revenue Growth Rate 2014-2019 (Million USD) Table Southeast Asia Neurodegenerative Drugs Production, Consumption Import and Export (MT) Figure India Neurodegenerative Drugs Production Growth Rate 2014-2019 (MT) Figure India Neurodegenerative Drugs Revenue Growth Rate 2014-2019 (Million USD) Table India Neurodegenerative Drugs Production, Consumption Import and Export (MT) Figure Global Consumption Neurodegenerative Drugs Market Share by Application (2014-2019) Figure Global Value (Consumption) Neurodegenerative Drugs Market Share by Application (2014-2019) Table Novartis Neurodegenerative Drugs Production Sites and Area Served Table Novartis Neurodegenerative Drugs Product Introduction, Application and Specification Table Novartis Neurodegenerative Drugs Production (MT), Revenue (Million USD), Ex-factory Price (USD/Kg) and Gross Margin (2014-2019) Table Novartis Neurodegenerative Drugs Production Growth Rate (2014-2019) Table Novartis Neurodegenerative Drugs Production Market Share (2014-2019) Figure Novartis Neurodegenerative Drugs Revenue Market Share (2014-2019) Table Novartis Neurodegenerative Drugs Main Business and Markets Served Table Pfizer Neurodegenerative Drugs Production Sites and Area Served Table Pfizer Neurodegenerative Drugs Product Introduction, Application and Specification Table Pfizer Neurodegenerative Drugs Production (MT), Revenue (Million USD), Ex-factory Price (USD/Kg) and Gross Margin (2014-2019) Table Pfizer Neurodegenerative Drugs Production Growth Rate (2014-2019) Table Pfizer Neurodegenerative Drugs Production Market Share (2014-2019) Figure Pfizer Neurodegenerative Drugs Revenue Market Share (2014-2019) Table Pfizer Neurodegenerative Drugs Main Business and Markets Served Table Merck Serono Neurodegenerative Drugs Production Sites and Area Served Table Merck Serono Neurodegenerative Drugs Product Introduction, Application and Specification Table Merck Serono Neurodegenerative Drugs Production (MT), Revenue (Million USD), Ex-factory Price (USD/Kg) and Gross Margin (2014-2019) Table Merck Serono Neurodegenerative Drugs Production Growth Rate (2014-2019) Table Merck Serono Neurodegenerative Drugs Production Market Share (2014-2019) Figure Merck Serono Neurodegenerative Drugs Revenue Market Share (2014-2019) Table Merck Serono Neurodegenerative Drugs Main Business and Markets Served Table Biogen Idec Neurodegenerative Drugs Production Sites and Area Served Table Biogen Idec Neurodegenerative Drugs Product Introduction, Application and Specification Table Biogen Idec Neurodegenerative Drugs Production (MT), Revenue (Million USD), Ex-factory Price (USD/Kg) and Gross Margin (2014-2019) Table Biogen Idec Neurodegenerative Drugs Production Growth Rate (2014-2019) Table Biogen Idec Neurodegenerative Drugs Production Market Share (2014-2019) Figure Biogen Idec Neurodegenerative Drugs Revenue Market Share (2014-2019) Table Biogen Idec Neurodegenerative Drugs Main Business and Markets Served Table TEVA Pharmaceuticals Neurodegenerative Drugs Production Sites and Area Served Table TEVA Pharmaceuticals Neurodegenerative Drugs Product Introduction, Application and Specification Table TEVA Pharmaceuticals Neurodegenerative Drugs Production (MT), Revenue (Million USD), Ex-factory Price (USD/Kg) and Gross Margin (2014-2019) Table TEVA Pharmaceuticals Neurodegenerative Drugs Production Growth Rate (2014-2019) Table TEVA Pharmaceuticals Neurodegenerative Drugs Production Market Share (2014-2019) Figure TEVA Pharmaceuticals Neurodegenerative Drugs Revenue Market Share (2014-2019) Table TEVA Pharmaceuticals Neurodegenerative Drugs Main Business and Markets Served Table UCB Neurodegenerative Drugs Production Sites and Area Served Table UCB Neurodegenerative Drugs Product Introduction, Application and Specification Table UCB Neurodegenerative Drugs Production (MT), Revenue (Million USD), Ex-factory Price (USD/Kg) and Gross Margin (2014-2019) Table UCB Neurodegenerative Drugs Production Growth Rate (2014-2019) Table UCB Neurodegenerative Drugs Production Market Share (2014-2019) Figure UCB Neurodegenerative Drugs Revenue Market Share (2014-2019) Table UCB Neurodegenerative Drugs Main Business and Markets Served Table Boehringer Ingelheim Neurodegenerative Drugs Production Sites and Area Served Table Boehringer Ingelheim Neurodegenerative Drugs Product Introduction, Application and Specification Table Boehringer Ingelheim Neurodegenerative Drugs Production (MT), Revenue (Million USD), Ex-factory Price (USD/Kg) and Gross Margin (2014-2019) Table Boehringer Ingelheim Neurodegenerative Drugs Production Growth Rate (2014-2019) Table Boehringer Ingelheim Neurodegenerative Drugs Production Market Share (2014-2019) Figure Boehringer Ingelheim Neurodegenerative Drugs Revenue Market Share (2014-2019) Table Boehringer Ingelheim Neurodegenerative Drugs Main Business and Markets Served Table Sanofi Neurodegenerative Drugs Production Sites and Area Served Table Sanofi Neurodegenerative Drugs Product Introduction, Application and Specification Table Sanofi Neurodegenerative Drugs Production (MT), Revenue (Million USD), Ex-factory Price (USD/Kg) and Gross Margin (2014-2019) Table Sanofi Neurodegenerative Drugs Production Growth Rate (2014-2019) Table Sanofi Neurodegenerative Drugs Production Market Share (2014-2019) Figure Sanofi Neurodegenerative Drugs Revenue Market Share (2014-2019) Table Sanofi Neurodegenerative Drugs Main Business and Markets Served Table GlaxoSmithKline Neurodegenerative Drugs Production Sites and Area Served Table GlaxoSmithKline Neurodegenerative Drugs Product Introduction, Application and Specification Table GlaxoSmithKline Neurodegenerative Drugs Production (MT), Revenue (Million USD), Ex-factory Price (USD/Kg) and Gross Margin (2014-2019) Table GlaxoSmithKline Neurodegenerative Drugs Production Growth Rate (2014-2019) Table GlaxoSmithKline Neurodegenerative Drugs Production Market Share (2014-2019) Figure GlaxoSmithKline Neurodegenerative Drugs Revenue Market Share (2014-2019) Table GlaxoSmithKline Neurodegenerative Drugs Main Business and Markets Served Figure Global Neurodegenerative Drugs Production (MT) Growth Rate Forecast 2019-2025 Figure Global Neurodegenerative Drugs Revenue (Million USD) Growth Rate Forecast 2019-2025 Figure Global Neurodegenerative Drugs Sales Price (USD/Kg) Forecast 2019-2025 Figure North America Neurodegenerative Drugs Production Growth Rate Forecast 2019-2025 (MT) Figure North America Neurodegenerative Drugs Revenue Growth Rate Forecast 2019-2025 (Million USD) Figure Europe Neurodegenerative Drugs Production Growth Rate Forecast 2019-2025 (MT) Figure Europe Neurodegenerative Drugs Revenue Growth Rate Forecast 2019-2025 (Million USD) Figure China Neurodegenerative Drugs Production Growth Rate Forecast 2019-2025 (MT) Figure China Neurodegenerative Drugs Revenue Growth Rate Forecast 2019-2025 (Million USD) Figure Japan Neurodegenerative Drugs Production Growth Rate Forecast 2019-2025 (MT) Figure Japan Neurodegenerative Drugs Revenue Growth Rate Forecast 2019-2025 (Million USD) Figure Southeast Asia Neurodegenerative Drugs Production Growth Rate Forecast 2019-2025 (MT) Figure Southeast Asia Neurodegenerative Drugs Revenue Growth Rate Forecast 2019-2025 (Million USD) Figure India Neurodegenerative Drugs Production Growth Rate Forecast 2019-2025 (MT) Figure India Neurodegenerative Drugs Revenue Growth Rate Forecast 2019-2025 (Million USD) Table Global Production (MT) of Neurodegenerative Drugs by Type (2019-2025) Table Global Consumption (MT) of Neurodegenerative Drugs by Application (2019-2025) Table Neurodegenerative Drugs Distributors List Table Neurodegenerative Drugs Customers List Table Market Key Trends Table Key Opportunities Table Market Key Drivers Table Key Challenges Table Key Influence Factors Table Research Programs/Design for This Report Figure Bottom-up and Top-down Approaches for This Report Figure Data Triangulation Table Key Data Information from Secondary Sources Table Key Data Information from Primary Sources

Novartis Pfizer Merck Serono Biogen Idec TEVA Pharmaceuticals UCB Boehringer Ingelheim Sanofi GlaxoSmithKline